Home » Topics » BioWorld Science

BioWorld Science
RSS

New multitargeted PARP, PI3K and/or BRD4 inhibitors disclosed by SignalRx Pharmaceuticals

Jan. 14, 2019

Novartis presents lysine-specific histone demethylase 1A inhibitors

Jan. 14, 2019

Phase II trial of varlitinib in advanced gastric cancer does not meet primary endpoint

Jan. 14, 2019

2-Acylglycerol O-acyltransferase 2 inhibitors identified at Shionogi

Jan. 14, 2019

Mirati Therapeutics initiates phase I/II study of MRTX-849

Jan. 14, 2019

Meiji Seika Pharma, Kaken Pharmaceutical patent nuclear receptor RORgamma antagonists

Jan. 14, 2019

Brown University and Bryant University describe new antibacterials

Jan. 14, 2019

Enrollment ongoing in first-in-human study of PBF-1650

Jan. 14, 2019

E. coli toxin produced in unexpected ways

Jan. 14, 2019

Autologous exosomes deliver chemotherapy

Jan. 14, 2019